Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
TARS
TARS News & Events
-
Add to Watchlist
Trade TARS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
TARS News
Tarsus Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 24 2026
seekingalpha
Tarsus Pharmaceuticals Reports Narrowed Losses in 2025 Financials
Feb 24 2026
NASDAQ.COM
Tarsus Pharmaceuticals Q4 Earnings Analysis
Feb 23 2026
seekingalpha
Tarsus Pharmaceuticals Appoints New Board Member
Feb 18 2026
Newsfilter
From Olema to Insmed: Do These Soaring Biotechs Still Present a Good Investment Opportunity?
Nov 19 2025
NASDAQ.COM
Tarsus Pharmaceuticals, Inc. (TARS) Posts Q3 Loss but Exceeds Revenue Projections
Nov 05 2025
NASDAQ.COM
Tarsus Sets Q4 Sales Goal of $140M–$145M Amidst Increased XDEMVY Adoption and Pipeline Development
Nov 04 2025
SeekingAlpha
HC Wainwright & Co. Reaffirms Buy Rating for Tarsus Pharmaceuticals and Increases Price Target to $88
Oct 20 2025
Benzinga
Show More News
TARS Events
02/24 10:10
Tarsus Pharmaceuticals Stock Rises 11.6% to $77.64
Tarsus Pharmaceuticals is up 11.6%, or $8.05 to $77.64.
Show More Events
TARS Monitor News
Tarsus Pharmaceuticals Appoints David Pyott to Board, Boosting Growth Potential
Feb 24 2026
TARS Earnings Analysis
No Data
People Also Watch
